BriaCell Therapeutics Corp. (BCTXZ)West Vancouver, Canada | NasdaqCM
0.14 USD
+0.01
(4.392%)
⇧
(April 17, 2026, 4 p.m.
EDT)
Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 9:48 p.m. EDT
High-risk speculative trap: Despite a potential Phase 3 treatment milestone and strong balance sheet liquidity, the stock is trading at a negligible fraction of book value (-89% ROA) with no dividend history and zero directional forecast for the next 45 days, rendering it unsuitable for capital preservation. |
| Attribute | Value |
|---|---|
| Beta | 1.63 |
| Website | https://briacell.com |
| Attribute | Value |
|---|---|
| Address1 | Bellevue Centre |
| Address2 | Suite 300 235 -15th Street |
| Ask | 1.45 |
| Ask Size | 1 |
| Beta | 1.626 |
| Bid | 0.928 |
| Bid Size | 1 |
| Book Value | 4.264 |
| City | West Vancouver |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Canada |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.1426 |
| Current Ratio | 10.102 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.15 |
| Day Low | 0.13 |
| Display Name | BriaCell Therapeutics |
| Ebitda | -30,630,110 |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 604 921 1898 |
| Fifty Two Week High | 0.15 |
| Fifty Two Week High Change | -0.007400006 |
| Fifty Two Week High Change Percent | -0.04933337 |
| Fifty Two Week Low | 0.13 |
| Fifty Two Week Low Change | 0.012600005 |
| Fifty Two Week Low Change Percent | 0.09692311 |
| Fifty Two Week Range | 0.13 - 0.15 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,772,807,400,000 |
| Float Shares | 6,410,301 |
| Free Cashflow | -20,493,214 |
| Full Exchange Name | NasdaqCM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,025-04-25 |
| Language | en-US |
| Long Business Summary | BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada. |
| Long Name | BriaCell Therapeutics Corp. |
| Market | us_market |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_262266102 |
| Net Income To Common | -29,637,656 |
| Open | 0.1479 |
| Operating Cashflow | -30,967,316 |
| Operating Margins | 0.0 |
| Phone | 604 921 1810 |
| Previous Close | 0.1366 |
| Price Hint | 4 |
| Price To Book | 0.033442777 |
| Profit Margins | 0.0 |
| Quick Ratio | 9.387 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0059999973 |
| Regular Market Change Percent | 4.3923845 |
| Regular Market Day High | 0.15 |
| Regular Market Day Low | 0.13 |
| Regular Market Day Range | 0.13 - 0.15 |
| Regular Market Open | 0.1479 |
| Regular Market Previous Close | 0.1366 |
| Regular Market Price | 0.1426 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 4,635 |
| Return On Assets | -0.89438003 |
| Return On Equity | -1.7920799 |
| Sand P52 Week Change | 0.38150132 |
| Sector | |
| Sector Key | |
| Short Name | BriaCell Therapeutics Corp. War |
| Source Interval | 15 |
| State | BC |
| Symbol | BCTXZ |
| Total Cash | 29,903,628 |
| Total Cash Per Share | 4.124 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 4,635 |
| Website | https://briacell.com |
| Zip | V7T 2X1 |